News from NYU Langone Health
The 2024 Health Care Power 100. (City & State (NY))
City & State (NY) (1/16) presents City & State’s Health Care Power 100 list for 2024, which “features hospital and health care executives, nonprofit service providers, labor leaders, academics and other advocates and activists who are shaping health care policy and practice in New York.” At position 23 on the list is Robert I. Grossman, MD, dean and CEO, NYU Langone Health, noting that in July the Long Island Langone School of Medicine was also named for Grossman when it, too, became tuition-free for students.
Walking Pad Review: Mini Treadmill Helped Me Hit My Step Goals. (TODAY)
TODAY (1/16) Walking pads are “‘really for walking or very light jogging,’ N’Namdi Nelson, CSCS, exercise physiologist, Sports Performance Center Team, tells TODAY.com.”
Health Matters: Everything You Need to Know About Medulloblastoma Brain Cancer. (Essence Magazine)
Essence Magazine (1/12) “According to Benjamin Cooper, MD, assistant professor, Department of Radiation Oncology, Perlmutter Cancer Center at NYU Langone Perlmutter Cancer Center, ‘Medulloblastoma is the most common brain tumor in children.’”
$250B Of U.S. Health Costs Could Be Tied to Exposure to Chemicals in Plastics. (Physician's Weekly)
Physician’s Weekly (1/17) “Leonardo Trasande, MD, MPP, the Jim G. Hendrick, M.D. Professor of Pediatrics, professor, Department of Population Health in New York City,” who is the Jim G. Hendrick, M.D. Professor of Pediatrics as well as a professor in the Department of Population Health at NYU Langone, “and colleagues calculated the attributable disease burden and cost due to chemicals used in plastic materials in 2018.”
Would You Eat a Lollipop Without Candy? Turns Out the Flu Virus Won’t, Either. (FierceBiotech)
FierceBiotech (1/16) “In a study published Jan. 11 in the American Society for Microbiology’s academic journal mBio, scientists from New York University Langone Health and Grossman School of Medicine described how they found that using an enzyme to temporarily remove compounds called sialic acids in the nasal passages of infant mice dramatically cut transmission between them,” leading study lead Mila B. Ortigoza, MD, PhD, assistant professor, Department of Medicine, Division of Infectious Diseases, and Department of Microbiology, to tell Fierce Biotech Research, “This was a very proof-of-concept, preclinical study that demonstrated that we can do this if we use this approach.”
Also reporting is Express Healthcare Management (1/16)*.
Ultrafine Particle Exposure Heightens Risk for Respiratory Mortality. (Healio)
Healio (1/16) “With more evidence on the risks linked to these” ultrafine “particles, new pollution regulations could arise, according to an accompanying editorial by George D. Thurston, PhD, professor, Departments of Medicine, Division of Environmental Medicine, and Department of Population Health.”
Survey: Most Adults Would Consider Living Kidney Donation If Certain Factors Were Met. (Healio)
Healio (1/16) “Results from a recently published U.S. survey show that most adults would consider becoming a living kidney donor, and donation rates could increase with culturally competent education,” leading Katya Kaplow, MPH, quantitative data analyst, Department of Surgery at New York University Langone, and colleagues to write, “Understanding national trends ... will enable us to identify and address existing disincentives [to donation].”
Mpox Vaccine: Does HIV Status, Administration Route Affect Immunogenicity? (Dermatology Advisor)
Dermatology Advisor (1/16) “For participants who were previously vaccinated against smallpox, the GMT of anti-H3L IgG antibodies after receipt of 2 mpox vaccine doses was 670.34 and the mean titer was 676.84, with a vaccine half-life of 291.2 days,” which, “according to a press release from NYU Langone Health, these trends indicated that previous receipt of the smallpox vaccine was associated with a 2.7-times higher antibody response.”
The Future Is Here: Synthetic Yeast Genome Nears Completion with New Milestone. (SciTech Daily)
SciTech Daily (1/16) “A team of scientists from the United Kingdom, including leading experts from the University of Nottingham and Imperial College London,” as well as scientists from a number of universities, including NYU Langone Health, “have successfully constructed a synthetic chromosome.”
No Fasting Before PCI? Study Shows No Harm – and Happier Patients. (TCTMD)
TCTMD (1/16) “Sripal Bangalore, MD, professor, Department of Medicine, the Leon H. Charney Division of Cardiology (NYU Langone Health, New York, NY), who chaired the writing committee for” a “scientific statement on evidence-based practices in the cath lab,” had “told TCTMD that while the study is small and consists of mostly white men, it is further confirmation of what many have long believed in terms of the need for NPO orders for cardiac catheterization patients.”
Teamwork: A Multidisciplinary Approach to Early Lung Cancer. (Medscape)
Paywalled* Medscape (1/12)* “A team comprising a pulmonologist, radiation oncologist, thoracic surgeon, and medical oncologist” – Daniel H. Sterman, MD, the Thomas and Suzanne Murphy Professor of Pulmonary and Critical Care Medicine, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, professor, Department of Cardiothoracic Surgery, Perlmutter Cancer Center; Abraham Chachoua, MD, the Antonio Magliocco, Jr. Professor of Medicine, Department of Medicine, Division of Hematology and Medical Oncology professor, Department of Urology, Perlmutter Cancer Center; Elaine Shum, MD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center; Amie J. Kent, MD, clinical assistant professor, Department of Cardiothoracic Surgery, Perlmutter Cancer Center; Benjamin Cooper, MD, assistant professor, Department of Radiation Oncology, Perlmutter Cancer Center; and Anissa Walker, MSN, Department of Interventional Pulmonology, Perlmutter Cancer Center – “explores the evolution of NSCLC care and how their coordinated efforts as a multidisciplinary team individualize the treatment plan for each of their NSCLC patients.”
(Free log-in required.)
The VA’s Approach to Prostate Cancer: Treatment and Support Services. (SurvivorNet)
SurvivorNet (1/11) “Michael J. Zelefsky, MD, vice chair for academic and faculty affairs, professor, Department of Radiation Oncology, Perlmutter Cancer Center, has this to say about the importance of having a care team behind you, ‘Understanding the different aspects of the disease, understanding the impact that it could have on quality of life and then addressing it with a therapy that they’re comfortable with, I think will give them great solace and great peace of mind knowing that they’re going in a direction that they’re comfortable with.’”
Why Men with Advanced Prostate Cancer Should Get the Hugely Important New PSMA PET Scan. (SurvivorNet)
SurvivorNet (1/11) “PSMA PET has shown exceptional accuracy in detecting both primary and metastatic prostate cancer,” leading Alberto Vargas, MD, member of the faculty, Department of Radiology, Division of Oncologic Imaging and Radiology, Perlmutter Cancer Center to say, “Things that we were previously unable to detect because they were so small with other modalities, all of a sudden, light up.”
The Role of ‘Theranostics’ in Prostate Cancer Diagnosis and Treatment. (SurvivorNet)
SurvivorNet (1/10) Theranostics, “unlike chemotherapy, which affects both cancerous and healthy cells,” minimizes side effects through its precision, which “is the key to its effectiveness, David R. Wise, MD, PhD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, and Department of Urology, Perlmutter Cancer Center” told SurvivorNet.
NUBEQA to Treat Advanced Stage Prostate Cancer. (SurvivorNet)
SurvivorNet (1/11) “‘NUBEQA, or darolutamide, is the fourth in a list of novel hormonal agents – or second generation androgen receptor directed therapies that we now have in the market,’ says David R. Wise, MD, PhD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, and Department of Urology, Perlmutter Cancer Center.”
Pluvicto Provides Hope for Veterans with Metastatic Prostate Cancer. (SurvivorNet)
SurvivorNet (1/10) “‘ given a significant part of their life for the service of our country, and we always start with a recognition of that and we really always try to make sure that we’re really giving back to them like the way they gave to all of us,’ David R. Wise, MD, PhD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, and Department of Urology, Perlmutter Cancer Center, told SurvivorNet.”
NeuroArts Symposium ‘Rhythms for the Brain’ Coming to Kravis Center in March. (Palm Beach Christian Voice)
Palm Beach Christian Voice (1/16) “There is a lightness in the air that permeates the newly developed classes and gatherings of the Mind Music Movement Foundation for Neurological Disorders” where “Steven J. Frucht, MD, professor, Department of Neurology, associate chair for neurology faculty group practices serves as the Medical Director.”
Why Aren’t Folks Filling Heart Medication Prescriptions? (Sacramento (CA) Observer)
The Sacramento (CA) Observer (1/17) “A team of researchers at New York University’s (NYU) Grossman School of Medicine found a staggering gap in heart medication adherence along economic lines,” which “‘highlight the importance of considering neighborhood socioeconomic status when developing interventions to ensure people with heart failure have access to their medications,’ Amrita Mukhopadhyay, MD, the Eugene Braunwald Assistant Professor of Cardiology, Department of Medicine, the Leon H. Charney Division of Cardiology said in a statement.”
New Findings on Sudden Infant Death Syndrome. (The Limited Times)
The Limited Times (1/16) The study of sudden infant death syndrome through video recordings from home cameras “‘may also provide important insights into many other deaths, such as those caused by epilepsy,’ the study’s lead researcher,” Orrin Devinsky, MD, professor, Departments of Neurology, Neurosurgery, Psychiatry, director, Comprehensive Epilepsy Center” said in a statement.
The Ever-Expanding Market for Rapid Weight Loss Is a Disaster in the Making. (Dr. Mercola's Censored Library)
Dr. Mercola’s Censored Library (1/16) “Telehealth has its place, but when it comes to weight loss drugs, in-person evaluations are important and shouldn’t be skipped,” with Melanie R. Jay, MD, associate professor, Department of Medicine, Division of General Internal Medicine, and Department of Population Health saying, “You get a much better sense of their functional status” with an in-person exam.
WeightWatchers Is Joining the GLP-1 Game. Here’s How Experts Feel About It. (Yahoo! Lifestyle)
Yahoo! Lifestyle (1/16) “‘There hasn’t been enough attention made to the type of support people need for GLP-1s,’ says Melanie R. Jay, MD, associate professor, Department of Medicine, Division of General Internal Medicine, and Department of Population Health.”
Mom’s Viral Clip Argues Parents Are Spending Too Much Time on Kids’ Activities. (Upworthy)
Upworthy (1/16) “‘The benign neglect movement seems to be a backswing from helicopter parenting, which encouraged coddling millennials and Gen Zs throughout childhood,’ Yamalis Diaz, PhD, clinical associate professor, Department of Child and Adolescent Psychiatry told The New York Post.”
Cancer Causes: These Ten Hidden Carcinogens Can Raise the Risk, According to an Oncology Expert. (Fox News)
Fox News (1/16) “Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and a Fox News medical contributor, described” Dr. John Oertle’s list “of some of these hidden carcinogens, their sources and the types of cancer they cause” as “important.”
News from NYU Langone Hospital—Long Island
Enabling Prostate Cancer Conversations: How to Get Comfortable Talking About Symptoms & Side Effects. (SurvivorNet)
SurvivorNet (1/11) “‘A lot of what we’re focusing on is minimizing impact on quality of life,’ says Jonathan W. Lischalk, MD, associate professor, Department of Radiation Oncology, NYU Langone Hospital–Long Island, Perlmutter Cancer Center” and NYU Langone Perlmutter Cancer Center.
What Happens If My PSA Test Is Elevated? (SurvivorNet)
SurvivorNet (1/10) “‘So for a patient that’s found to have an elevated PSA, oftentimes it’s the urologist that meets that patient first, typically referred from a primary care physician,’ Jonathan W. Lischalk, MD, associate professor, Department of Radiation Oncology, NYU Langone Hospital–Long Island, Perlmutter Cancer Center,” explains.
